Categories AlphaGraphs, Earnings, Health Care
Eli Lilly (LLY) reports Q1 2020 earnings results
Adjusts EPS guidance amid COVID19 pandemic
Pharmaceutical company Eli Lilly (NYSE: LLY) reported first quarter 2020 revenue of $5.86 billion, up 15% year-over-year.
Amid COVID-19 pandemic, the company saw increased customer buying patterns and prescription trends which resulted in revenue increase of approx. $250 million for the quarter.
Net income was $1.457 billion or $1.60 per share, compared with net income of $4.242 billion or $4.31 per in the first quarter of 2019.
Josh Smiley, CFO commented on the outlook:
“Our revenue and operating margin outlook for 2020 is unchanged, but the economic and healthcare consequences of this pandemic are uncertain and could negatively affect our financial results later in 2020 and beyond, due to reduced non-COVID healthcare activities and global economic challenges. We are therefore widening the range of our 2020 EPS guidance to reflect both our underlying strong performance as well as future uncertainty; however, the long-term fundamentals of our business remain strong, as does our financial outlook for the mid-2020s and beyond.”
Past Performance
Most Popular
Spotify (SPOT) Earnings: 3Q24 Key Numbers
Spotify Technology S.A. (NYSE: SPOT) reported total revenue of EUR3.98 billion for the third quarter of 2024, up 19% year-over-year. Net income attributable to owners of the parent was EUR300
Nvidia (NVDA) looks poised to deliver blowout results once again
After a blockbuster first half, Nvidia Corporation (NASDAQ: NVDA) is preparing to publish data on its third-quarter financial performance next week. Since the company is expected to provide updates on
Key takeaways from Tyson Foods’ (TSN) Q4 2024 earnings report
Shares of Tyson Foods, Inc. (NYSE: TSN) jumped over 8% on Tuesday after the company delivered better-than-expected earnings results for the fourth quarter of 2024. Revenue and earnings beat estimates,